Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations - Wikidata - awgldk - TriplyDB

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations

http://www.wikidata.org/entity/Q28386233

about

Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesis Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study BRCA1 mutations do not increase prostate cancer risk: results from a meta-analysis including new data.BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood.Immunohistochemical expression of BRCA1 and lethal prostate cancer.Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.Genome-wide linkage scan for prostate cancer susceptibility in Finland: evidence for a novel locus on 2q37.3 and confirmation of signal on 17q21-q22.The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera.Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study.The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers Interest of individuals from BRCA families to participate in research studies focused on male BRCA carriers Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population.Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2.Characterization of human papillomavirus type 120: a novel betapapillomavirus with tropism for multiple anatomical niches.A comparison of the polytomous logistic regression and joint cox proportional hazards models for evaluating multiple disease subtypes in prospective cohort studies Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer.Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.The role of BRCA1 and BRCA2 in prostate cancer.New insights into the prevention and treatment of familial breast cancer.Nucleic acid-based tissue biomarkers of urologic malignancies.Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer.Case report: human papilloma virus type 120-related papillomatosis mimicking laryngeal carcinoma.Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.Update on Screening for Urological Malignancies.Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.Germline BRCA mutation in male carriers-ripe for precision oncology?Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.PSA testing: Molecular technologies and men's experience of prostate cancer survivorship

P2860

Q27347240-868CBBD8-FFA5-4FBD-A052-1D49EF7E143E Q33609681-7A55CC9F-E25B-400F-9E45-3307013E077C Q33881971-629F3F70-F8C6-4B41-B62D-BCAA81CBCBC2 Q34589804-D792642C-8D8A-4633-B2F8-7442DB6CE76A Q34626692-2B256B70-9F60-455A-82D7-56FBCBCFBB94 Q34661857-4DA05F08-BA18-4BCA-8571-DF78CF43B6AF Q34838226-A9A2E939-8F38-44F1-867A-A6CEC716F502 Q35109839-C4DF07BF-711E-4EFB-9529-1E543857AE6E Q35164443-B8079D24-E268-4EE7-973C-9EF8792FAEDB Q35687887-5A42AFE0-3289-4C95-B4BF-AA0FF2A89D14 Q35906685-12F88A2C-A0E5-44FE-A2E9-D9CB27831247 Q35907075-462247D9-079C-4F0B-ABFB-6EC31DD3C8EB Q36028638-71C9D9FE-9D09-423D-A614-9B3AFAF5B0C2 Q36113139-0661FE30-F92F-4FF1-81F9-D34881F18C7F Q36252996-1C0CD3AA-EC4A-4B11-B09A-A60AA8AFD2D2 Q36523118-2D56CF9A-AD17-4558-A9FD-6A2F0F6B3D53 Q36589083-EED5EB32-0FE2-4671-B5A6-BBF3DF82BB39 Q36818918-936E89E7-DB0A-488B-B94B-63A4B865DCD3 Q37019841-27F8CA46-8355-4205-89A7-3B49CB35F95E Q37037789-C8D51056-36B1-491A-95A2-AC3ECBF81E9A Q37845305-BFE8AAED-D4B3-4916-A683-A8A51A6C1EA5 Q38216131-50C56F2C-DA9E-472E-B4AC-80A94C58E6D7 Q38893354-3E573A3F-4DE2-41B0-9708-CC22E3CF423F Q40189752-9F2BD2E5-C180-4138-AD20-536E287F3F95 Q40718874-E9880AF9-B5F4-453B-8A12-F370DE9CE3F9 Q42649779-4BD2620A-47EE-4B50-94B1-30652DDBC5C2 Q46083971-17B491C5-FDAA-463D-8E40-7BD49863ECBF Q46798905-17C9432B-5011-4D25-9296-8389C1D4FEF6 Q52566012-2DD5BD88-4C0E-4A2C-B6FD-57196A2AB3C7 Q57603428-D511952E-1DBF-4B8A-8AEE-87AC3076A28D

P2860

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations

http://www.wikidata.org/entity/Q28386233

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations

@ast

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations

@en

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations

@nl

type

label

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations

@ast

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations

@en

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations

@nl

prefLabel

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations

@ast

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations

@en

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations

@nl

P1433

Q28386233-43DABF00-5973-47E3-A318-F8F7ED3245A7

P1476

Q28386233-112EFC25-9891-47A1-881C-75B82EC34141

P2093

Q28386233-3D6CAE00-A340-4994-9A13-2B12FEC93893

Q28386233-5C168CC1-430A-479F-91B3-90A1F724A563

Q28386233-74F57857-7B2E-4986-9A1B-7A075472FECD

Q28386233-787897F8-2CD0-4C95-805C-375E0CDFB156

P2860

Q28386233-032C5E9C-B1D1-4BCC-8356-FC1645A845F3

Q28386233-035BAABA-8651-4E2F-A5FA-C9B60E456A86

Q28386233-0CCE523A-838C-48D3-AA3C-2D9DD3A15324

Q28386233-120C1BCD-2967-467D-B93F-14529565A276

Q28386233-19D2A506-904A-41AB-A1C8-2B781AA6E7F9

Q28386233-243C24D4-1BF0-40F6-A09A-A46F62A6D3FB

Q28386233-29A9AE7D-1F63-4D74-96EA-1C4CA02B61FA

Q28386233-33FECCFA-D435-4210-AD0D-595FDE51461D

Q28386233-34518F09-0604-4F87-ADDE-FF7AE34DAD08

Q28386233-3AB44E12-C754-4C4B-9E43-A741F71BB672

P304

Q28386233-8CD45898-4F3E-4545-9E2E-6E1CC5C3D351

P31

Q28386233-6547B4A5-D386-4EEC-ACDF-F20A4FE0BA04

P3181

Q28386233-EFE68028-2C84-464A-B596-2722FA92DD0D

P356

Q28386233-AF370276-220F-43FC-B77E-306F5D33C9A9

P407

Q28386233-7E0ACD62-C307-4C59-91E0-E0072BAF9FBE

P433

Q28386233-90F64265-0F71-42DF-B854-BB1D9B104BF3

P478

Q28386233-C6F34D32-C8CA-4270-8485-5D7792101381

P577

Q28386233-E5E7A3BF-2B7B-4F8C-B784-37E8609A8D21

P698

Q28386233-77BCD0FA-6A2F-4BCB-BE32-13BD7FBDB557

P932

Q28386233-1D56B1D0-3E09-40C0-B39F-E1EE079EEF99

P3181

P356

1078-0432.CCR-08-1822

P1433

Clinical Cancer Research

P1476

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations

@en

P2093

Ilir Agalliu

http://www.w3.org/2001/XMLSchema#string

Robert D Burk

http://www.w3.org/2001/XMLSchema#string

Robert Gern

http://www.w3.org/2001/XMLSchema#string

Suzanne Leanza

http://www.w3.org/2001/XMLSchema#string

P2860

Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients

Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer

Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

APC mutations occur early during colorectal tumorigenesis

The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

Identification of the von Hippel-Lindau disease tumor suppressor gene

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis.

P304

1112-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2285455

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1078-0432.CCR-08-1822

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19188187

http://www.w3.org/2001/XMLSchema#string

P932

3722558

http://www.w3.org/2001/XMLSchema#string